Literature DB >> 29421689

Diabetes Mellitus Associates with Increased Right Ventricular Afterload and Remodeling in Pulmonary Arterial Hypertension.

Morgan E Whitaker1, Vineet Nair1, Shripad Sinari1, Parinita A Dherange2, Balaji Natarajan2, Lindsey Trutter1, Evan L Brittain3, Anna R Hemnes3, Eric D Austin4, Kumar Patel1, Stephen M Black1, Joe G N Garcia1, Jason X Yuan Md PhD1, Rebecca R Vanderpool1, Franz Rischard1, Ayako Makino1, Edward J Bedrick1, Ankit A Desai5.   

Abstract

BACKGROUND: Diabetes mellitus is associated with left ventricular hypertrophy and dysfunction. Parallel studies have also reported associations between diabetes mellitus and right ventricular dysfunction and reduced survival in patients with pulmonary arterial hypertension. However, the impact of diabetes mellitus on the pulmonary vasculature has not been well characterized. We hypothesized that diabetes mellitus and hyperglycemia could specifically influence right ventricular afterload and remodeling in patients with Group I pulmonary arterial hypertension, providing a link to their known susceptibility to right ventricular dysfunction.
METHODS: Using an adjusted model for age, sex, pulmonary vascular resistance, and medication use, associations of fasting blood glucose, glycated hemoglobin, and the presence of diabetes mellitus were evaluated with markers of disease severity in 162 patients with pulmonary arterial hypertension.
RESULTS: A surrogate measure of increased pulmonary artery stiffness, elevated pulmonary arterial elastance (P = .012), along with reduced log(pulmonary artery capacitance) (P = .006) were significantly associated with the presence of diabetes mellitus in patients with pulmonary arterial hypertension in a fully adjusted model. Similar associations between pulmonary arterial elastance and capacitance were noted with both fasting blood glucose and glycated hemoglobin. Furthermore, right ventricular wall thickness on echocardiography was greater in pulmonary arterial hypertension patients with diabetes, supporting the link between right ventricular remodeling and diabetes.
CONCLUSION: Cumulatively, these data demonstrate that an increase in right ventricular afterload, beyond pulmonary vascular resistance alone, may influence right ventricular remodeling and provide a mechanistic link between the susceptibility to right ventricular dysfunction in patients with both diabetes mellitus and pulmonary arterial hypertension.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes mellitus; Pulmonary arterial capacitance; Pulmonary arterial elastance; Pulmonary arterial hypertension

Mesh:

Year:  2018        PMID: 29421689      PMCID: PMC5963998          DOI: 10.1016/j.amjmed.2017.12.046

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  31 in total

1.  Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension.

Authors:  Srijoy Mahapatra; Rick A Nishimura; Paul Sorajja; Stephen Cha; Michael D McGoon
Journal:  J Am Coll Cardiol       Date:  2006-01-26       Impact factor: 24.094

Review 2.  Diabetes, hypertension, and cardiovascular disease: an update.

Authors:  J R Sowers; M Epstein; E D Frohlich
Journal:  Hypertension       Date:  2001-04       Impact factor: 10.190

3.  Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension.

Authors:  Ryan J Tedford; James O Mudd; Reda E Girgis; Stephen C Mathai; Ari L Zaiman; Traci Housten-Harris; Danielle Boyce; Benjamin W Kelemen; Anita C Bacher; Ami A Shah; Laura K Hummers; Fredrick M Wigley; Stuart D Russell; Rajeev Saggar; Rajan Saggar; W Lowell Maughan; Paul M Hassoun; David A Kass
Journal:  Circ Heart Fail       Date:  2013-09-01       Impact factor: 8.790

Review 4.  From Left Ventricular Hypertrophy to Dysfunction and Failure.

Authors:  Davide Lazzeroni; Ornella Rimoldi; Paolo G Camici
Journal:  Circ J       Date:  2016-02-05       Impact factor: 2.993

Review 5.  Fatty acid metabolism in pulmonary arterial hypertension: role in right ventricular dysfunction and hypertrophy.

Authors:  Megha Talati; Anna Hemnes
Journal:  Pulm Circ       Date:  2015-06       Impact factor: 3.017

Review 6.  Classification of Pulmonary Hypertension.

Authors:  Ronald J Oudiz
Journal:  Cardiol Clin       Date:  2016-08       Impact factor: 2.213

7.  Magnetic Resonance Imaging in the Prognostic Evaluation of Patients with Pulmonary Arterial Hypertension.

Authors:  Andrew J Swift; Dave Capener; Chris Johns; Neil Hamilton; Alex Rothman; Charlie Elliot; Robin Condliffe; Athanasios Charalampopoulos; Smitha Rajaram; Allan Lawrie; Michael J Campbell; Jim M Wild; David G Kiely
Journal:  Am J Respir Crit Care Med       Date:  2017-07-15       Impact factor: 21.405

8.  Trends in pulmonary hypertension mortality and morbidity.

Authors:  Alem Mehari; Orlando Valle; Richard F Gillum
Journal:  Pulm Med       Date:  2014-06-01

Review 9.  Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?

Authors:  Aastha Chawla; Rajeev Chawla; Shalini Jaggi
Journal:  Indian J Endocrinol Metab       Date:  2016 Jul-Aug

Review 10.  The Role of Hyperglycemia and Insulin Resistance in the Development and Progression of Pulmonary Arterial Hypertension.

Authors:  Daniel Grinnan; Grant Farr; Adam Fox; Lori Sweeney
Journal:  J Diabetes Res       Date:  2016-06-08       Impact factor: 4.011

View more
  9 in total

Review 1.  Pulmonary vascular dysfunction in metabolic syndrome.

Authors:  Conor Willson; Makiko Watanabe; Atsumi Tsuji-Hosokawa; Ayako Makino
Journal:  J Physiol       Date:  2018-09-12       Impact factor: 5.182

Review 2.  Emerging therapies: The potential roles SGLT2 inhibitors, GLP1 agonists, and ARNI therapy for ARNI pulmonary hypertension.

Authors:  Nicholas E King; Evan Brittain
Journal:  Pulm Circ       Date:  2022-01-18       Impact factor: 2.886

Review 3.  The Role of Thyroid Disorders, Obesity, Diabetes Mellitus and Estrogen Exposure as Potential Modifiers for Pulmonary Hypertension.

Authors:  Eleni Vrigkou; Evangeline Vassilatou; Effrosyni Dima; David Langleben; Anastasia Kotanidou; Marinella Tzanela
Journal:  J Clin Med       Date:  2022-02-10       Impact factor: 4.241

4.  The burden of comorbidities in pulmonary arterial hypertension.

Authors:  Irene M Lang; Massimiliano Palazzini
Journal:  Eur Heart J Suppl       Date:  2019-12-17       Impact factor: 1.803

5.  Metformin inhibits pulmonary artery smooth muscle cell proliferation by upregulating p21 via NONRATT015587.2.

Authors:  Zengxian Sun; Yun Liu; Rong Hu; Tianyan Wang; Yanli Li; Naifeng Liu
Journal:  Int J Mol Med       Date:  2022-02-11       Impact factor: 4.101

6.  Diabetes Mellitus Is an Independent Risk Factor for a Stiff Left Atrial Physiology After Catheter Ablation for Atrial Fibrillation.

Authors:  Moon-Hyun Kim; Hee Tae Yu; Yoon Jung Park; Tae-Hoon Kim; Boyoung Joung; Moon-Hyoung Lee; Hui-Nam Pak
Journal:  Front Cardiovasc Med       Date:  2022-03-28

7.  Pulmonary Arterial Hypertension Induces a Distinct Signature of Circulating Metabolites.

Authors:  Ruslan Rafikov; Dawn K Coletta; Lawrence J Mandarino; Olga Rafikova
Journal:  J Clin Med       Date:  2020-01-14       Impact factor: 4.241

8.  Prevalence of osteoporosis in patients with type 2 diabetes mellitus in the Chinese mainland: A protocol of systematic review and meta-analysis.

Authors:  Yuhao Si; Cenyi Wang; Yang Guo; Heng Yin; Yong Ma
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

9.  Associations of (pre)diabetes with right ventricular and atrial structure and function: the Maastricht Study.

Authors:  Pauline B C Linssen; Marja G J Veugen; Ronald M A Henry; Carla J H van der Kallen; Abraham A Kroon; Miranda T Schram; Hans-Peter Brunner-La Rocca; Coen D A Stehouwer
Journal:  Cardiovasc Diabetol       Date:  2020-06-15       Impact factor: 9.951

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.